Publication:
Time-dependent alterations in growth and bone health parameters evaluated at different posttreatment periods in pediatric oncology patients

dc.contributor.buuauthorDemirkaya, Metin
dc.contributor.buuauthorSevinir, Betül Berrin
dc.contributor.buuauthorSaǧlam, Halil
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPediatri Ana Bilim Dalı
dc.contributor.orcid0000-0003-0710-5422
dc.contributor.researcheridAAH-1570-2021
dc.contributor.researcheridC-7392-2019
dc.contributor.scopusid24331130000
dc.contributor.scopusid6603199915
dc.contributor.scopusid35612700100
dc.date.accessioned2022-02-18T11:16:15Z
dc.date.available2022-02-18T11:16:15Z
dc.date.issued2011-10
dc.description.abstractBone mineral density (BMD) and anthropometric measurements in pediatric cancer patients were evaluated and compared at early and late posttreatment periods. Sixty-six pediatric cancer patients who recovered completely following treatment longer than at least a 6-month period were included in the study. Patients were evaluated cross-sectionally and prospectively with regard to anthropometric measurements and BMD twice; the first being at a mean period of 2.62 +/- 1.44 years and the second of 6.55 +/- 1.71 years after the completion of treatment. Rates of osteoporosis and osteopenia at first or second evaluation were 25.8% and 39.4% or 10.6% and 19.7%, respectively. Mean BMD z-scores were (-1.26) +/- 1.12 [(-4.3)-2.0] and (-0.48) +/- 1.25 [(-3.30)-3.40] at first and second evaluations, respectively. BMD findings obtained at second evaluation revealed statistically significant recovery compared with those obtained at first evaluation (P = .001). BMD z-scores were significantly lower in patients who received, as opposed to those who did not receive, radiotherapy (RT) at both evaluations. Anthropometric parameters of patients such as height, weight, and body mass index (BMI) were increased at both evaluations compared with values obtained at diagnosis (P < .05). Height standard deviation score (SDS) decreased at first evaluation compared with that measured at diagnosis, whereas it increased at second evaluation. Conversely, weight SDS and BMI SDS increased (P < .05) at first evaluation compared with that measured at diagnosis, whereas they decreased at second evaluation. The authors conclude that early impairments in anthropometric measurements recover in the long term, whereas BMD is continually reduced in children who recovered from cancer.
dc.identifier.citationDemirkaya, M. vd. (2011). "Time-dependent alterations in growth and bone health parameters evaluated at different posttreatment periods in pediatric oncology patients". Pediatric Hematology and Oncology, 28(7), 588-599.
dc.identifier.endpage599
dc.identifier.issn0888-0018
dc.identifier.issn1521-0669
dc.identifier.issue7
dc.identifier.pubmed21936621
dc.identifier.scopus2-s2.0-80053069065
dc.identifier.startpage588
dc.identifier.urihttps://doi.org/10.3109/08880018.2011.603819
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.3109/08880018.2011.603819
dc.identifier.urihttp://hdl.handle.net/11452/24529
dc.identifier.volume28
dc.identifier.wos000295084800005
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.journalPediatric Hematology and Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectHematology
dc.subjectPediatrics
dc.subjectAnthropometric
dc.subjectBone mineral density
dc.subjectChildhood cancer survivors
dc.subjectAcute lymphoblastic-leukemia
dc.subjectLong-term survivors
dc.subjectMineral density
dc.subjectChildhood-cancer
dc.subjectBody-composition
dc.subjectChildren
dc.subjectChemotherapy
dc.subjectTherapy
dc.subjectTurnover
dc.subjectPrednisolone
dc.subject.emtreeCyclophosphamide
dc.subject.emtreeDexamethasone
dc.subject.emtreeEtoposide
dc.subject.emtreeEtoposide derivative
dc.subject.emtreeIfosfamide
dc.subject.emtreeMethotrexate
dc.subject.emtreePrednisolone
dc.subject.emtreeVinca alkaloid
dc.subject.emtreeAnthropometric parameters
dc.subject.emtreeArticle
dc.subject.emtreeBody height
dc.subject.emtreeBody mass
dc.subject.emtreeBody weight
dc.subject.emtreeBone density
dc.subject.emtreeBone growth
dc.subject.emtreeBone tumor
dc.subject.emtreeCancer chemotherapy
dc.subject.emtreeCancer patient
dc.subject.emtreeCancer radiotherapy
dc.subject.emtreeChild
dc.subject.emtreeChildhood cancer
dc.subject.emtreeFemale
dc.subject.emtreeGerm cell tumor
dc.subject.emtreeHodgkin disease
dc.subject.emtreeHuman
dc.subject.emtreeLong term care
dc.subject.emtreeLymphatic system tumor
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeNeoplasm
dc.subject.emtreeNonhodgkin lymphoma
dc.subject.emtreeOncology
dc.subject.emtreeOsteopenia
dc.subject.emtreeOsteoporosis
dc.subject.emtreePreschool child
dc.subject.emtreeProspective study
dc.subject.emtreeRetinoblastoma
dc.subject.emtreeScoring system
dc.subject.emtreeSoft tissue sarcoma
dc.subject.emtreeSolid tumor
dc.subject.meshAnthropometry
dc.subject.meshAntineoplastic combined chemotherapy protocols
dc.subject.meshBody height
dc.subject.meshBody mass index
dc.subject.meshBody weight
dc.subject.meshBone density
dc.subject.meshBone development
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshCross-sectional studies
dc.subject.meshFemale
dc.subject.meshFollow-up studies
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, newborn
dc.subject.meshMale
dc.subject.meshNeoplasm staging
dc.subject.meshNeoplasms
dc.subject.meshProspective studies
dc.subject.meshTime factors
dc.subject.meshTreatment outcome
dc.subject.scopusAcute Lymphoblastic Leukemia; Bone Density; Photon Absorptiometry
dc.subject.wosOncology
dc.subject.wosHematology
dc.subject.wosPediatrics
dc.titleTime-dependent alterations in growth and bone health parameters evaluated at different posttreatment periods in pediatric oncology patients
dc.typeArticle
dc.wos.quartileQ4
dc.wos.quartileQ3 (Pediatrics)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Pediatri Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: